✦ LIBER ✦

Bovine fibrinogen. II. Effects of tyrosine modification on fibrin monomer aggregation

✍ Scribed by Phillips, H. M.; York, J. Lyndal

Book ID: 127372847
Publisher: American Chemical Society
Year: 1973
Tongue: English
Weight: 698 KB
Volume: 12
Category: Article
ISSN: 0006-2960
DOI: 10.1021/bi00743a012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bovine fibrinogen. I. Effects of amidina

Bovine fibrinogen. I. Effects of amidination on fibrin monomer aggregation

✍ Phillips, H. M.; York, J. Lyndal 📂 Article 📅 1973 🏛 American Chemical Society 🌐 English ⚖ 694 KB

37. ACTION OF FIBRINOGEN DEGRADATION PRO

37. ACTION OF FIBRINOGEN DEGRADATION PRODUCTS AND FIBRIN MONOMER SOLUBLE COMPLEXES ON PLATELET AGGREGATION

✍ Larrieu, M.J. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 355 KB

CHEMICAL MODIFICATION OF FIBRINOGEN AND

CHEMICAL MODIFICATION OF FIBRINOGEN AND THE EFFECT ON FIBRIN FORMATION

✍ Y. Saito; A. Shimizu; A. Matsushima; Y. Inada 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Studies on Fibrin Monomer Aggregation in

Studies on Fibrin Monomer Aggregation in Congenital Dysfibrinogenaemia (Fibrinogen ‘Zürich’): Separation of a Pathological from a Normal Fibrin Fraction

✍ A. Von Felten; P. G. Frick; P. W. Straub 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

The effect of beam-plasma modification o

The effect of beam-plasma modification of fibrin monomer on its biological properties

✍ T. M. Vasil’eva; D. G. Chukhchin 📂 Article 📅 2008 🏛 SP MAIK Nauka/Interperiodica 🌐 English ⚖ 248 KB

Modification of fibrinogen with poly(eth

Modification of fibrinogen with poly(ethylene glycol) and its effects on fibrin clot characteristics

✍ Barker, T. H. ;Fuller, G. M. ;Klinger, M. M. ;Feldman, D. S. ;Hagood, J. S. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The suitability of existing topical fibrin glue preparations for tissue sealing or local drug delivery applications is greatly limited by their poor mechanical properties and the limited capacity of fibrinogen (Fgn) to actively bind growth factors or other therapeutic agents. Poly(ethylene glycol) (